MET logo

MetLife, Inc. Stock Price

NYSE:MET Community·US$54.3b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 50 Fair Values set on narratives written by author

MET Share Price Performance

US$85.57
5.95 (7.47%)
US$92.80
Fair Value
US$85.57
5.95 (7.47%)
7.8% undervalued intrinsic discount
US$92.80
Fair Value
Price US$85.57
AnalystConsensusTarget US$92.80

MET Community Narratives

·
Fair Value US$92.8 7.8% undervalued intrinsic discount

Digital Expansion And Employee Support Benefits Will Drive Outperformance Ahead

0users have liked this narrative
0users have commented on this narrative
26users have followed this narrative

Trending Discussion

Updated Narratives

MET logo

MET: Capital Returns And Product Flexibility Will Shape Future Risk Reward Balance

Fair Value: US$92.8 7.8% undervalued intrinsic discount
26 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Established dividend payer with mediocre balance sheet.

1 Risk
3 Rewards

MetLife, Inc. Key Details

US$77.6b

Revenue

US$59.2b

Cost of Revenue

US$18.4b

Gross Profit

US$15.0b

Other Expenses

US$3.4b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
5.34
23.75%
4.43%
178.0%
View Full Analysis

About MET

Founded
1999
Employees
46000
CEO
Michel Khalaf
WebsiteView website
www.metlife.com

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

Recent MET News & Updates

Seeking Alpha Jun 08

MetLife: Not Exciting, But It Works

Summary MetLife delivers strong Q1 2026 results with adjusted EPS up 23% to $2.42 and ROE at 17%, highlighting robust core performance. I find MET's fixed-income preferreds, especially Series F, compelling with yields near 6.5% and payout ratios under 4%, offering rare quality and safety. Common shares trade at a fair 8.5x forward P/E with limited near-term upside; total equity returns approximate 8% annually via buybacks and dividends. Key risks include commercial mortgage exposure and volatile alternative investment income, but preferred dividend coverage remains exceptionally strong. Read the full article on Seeking Alpha

Recent updates

No updates